Mar 9, 2023· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2019-N-2650-0014
The attached comments (FDA-2019-N-2650) are submitted on behalf of the Consumer Healthcare Products Association (CHPA) on March 9, 2023.
FDANonrulemakingFDA-2019-N-2650
Investigational New Drug Applications; Exemptions for Clinical Investigations to Evaluate a Drug Use of a Product Lawfully Marketed as a Conventional Food, Dietary Supplement, or Cosmetic
RIN
—
Last modified
Mar 10, 2023
Comment window
closed 1237d ago
Consumer Healthcare Products Association filings
1
Activity
Consumer Healthcare Products Association filed 1 comment on this docket between Mar 9, 2023 and Mar 9, 2023. 0 other organizations filed here. The comment window closed 1237d ago.
What Consumer Healthcare Products Association filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (0)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG1 filing · confidence 97%